Clinical Trial Update: Sustained Viral Response in Patients Achieved HBsAg Level≤100 IU/ml After Completed Interferon Treatment

View source ↗

Summary

This clinical trial update reports sustained viral response in patients with chronic hepatitis B who achieved HBsAg levels at 100 IU/mL or less after completing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Interferon (interferon)

Snippet

Sponsor: Beijing Ditan Hospital | Conditions: Chronic Hepatitis B | Status: UNKNOWN